PATENT CLAIM ANALYSIS

Application Number: 16075904
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "365000"]

Abstract:
The present application discloses a pharmaceutical preparation comprising a de-epoxidized epothilone derivative, and especially relates to a preparation formulation of a compound with reduced allergens and toxicity; and also relates to the use thereof in the treatment of tumours, especially the use thereof in the treatment of solid tumours that are resistant to and fail to respond to other conventional chemotherapeutic agents, as well as the use thereof in the treatment of cancers alone or in combination with other tumour drugs or auxiliary drugs.

Claim (Index 16):
The method according to  claim 8 , wherein the compound is administered for one treatment course of every 18-24 days; wherein from day 1 to day 5, the compound is administered by intravenous infusion once daily for consecutive 3 or 5 days.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.7451
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12763991', '13077766', '09863035', '13125303', '12855889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.71161022696439
- 35 USC 102 Novelty (BERT): 0.510333609951149
- Combined Prediction Score: 0.691482565263066
- Mean Citation Score: 248.371896
- Max Citation Score: 256.2341
- Similarity Product: 170.48602027013305

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test